Yahoo

Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results

Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results · Barrons.com · Courtesy Vera Therapeutics
Explore stocks on Coinbase

Vera Therapeutics takes a step toward securing full Food and Drug Administration approval for its injectable kidney drug, Trutakna.

Mobilize your Website
View Site in Mobile | Classic
Share by: